SCHEMBL2296809

SCHEMBL2296809

CCOC(=O)c1c(-c2ccc(N)cc2)noc1-c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.62
POLB P06746 2/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
ADORA3 P0DMS8 4/20 0.50
CACNA1F O60840 1/20 0.50
CACNA1D Q01668 1/20 0.50
CACNA1S Q13698 1/20 0.50
CACNA1C Q13936 1/20 0.50
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 4/20 0.49
LMNA P02545 3/20 0.49
HPGD P15428 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
PTBP1 P26599 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
HSD17B10 Q99714 2/20 0.48
RAB9A P51151 2/20 0.48
TP53 P04637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31526266 0.92 PTGS1 (0.72) PTGS1POLBALOX15TSHRMAPK1
SCHEMBL2761365 0.88 PTGS1 (0.62) PTGS1POLBALOX15TSHRMAPK1
SCHEMBL2296278 0.84 PTGS1 (0.57) PTGS1POLBALOX15TSHRMAPK1
SCHEMBL3940991 0.83 POLB (0.56) PTGS1POLBALOX15TSHRMAPK1
SCHEMBL899450 0.83 POLB (0.56) POLBALOX15TSHRMAPK1CACNA1F
SCHEMBL14790250 0.81 PTGS1 (0.54) PTGS1POLBALOX15TSHRMAPK1
SCHEMBL2776267 0.81 TSHR (0.70) POLBALOX15TSHRMAPK1CACNA1F
SCHEMBL4031918 0.80 ALDH1A1 (0.65) PTGS1POLBTSHRADORA3KDM4E
SCHEMBL536297 0.80 TSHR (0.74) POLBALOX15TSHRMAPK1CACNA1F
SCHEMBL14711121 0.80 PTGS1 (0.53) PTGS1POLBALOX15TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010023609-A1 OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-03-04 WO claimed
US-8835428-B2 Diacylglycerol acyltransferase inhibitors Piramal Enterprises Limited (IN) 2014-09-16 US disclosed
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED. 2011-08-11 US disclosed
WO-2010023609-A1 OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110196002-A1 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS DGAT1, DGAT2, DLAT PTGS1 1395/4885POLB 3062/4885ALOX15 282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.